LexDanaLexDanabeta
Inventor

STANTON F. MCHARDY

Inventor
US

Overview

5→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
A61KPreparations for medical, dental or toiletry purposes31%
C07DHeterocyclic compounds31%
PatentTitleYear
12,145,913Inhibition of Olig2 activity202411,691,951Inhibition of Olig2 activity202311,685,722Inhibition of Olig2 activity202311,304,916Methods and compositions for the treatment of Shiga Toxicosis202211,242,323Inhibition of OLIG2 activity2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to CURTANA PHARMACEUTICALS INC (4)· patent assignee history
2022Patents assigned to UNIV TEXAS (1)· patent assignee history
2022–2024Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CURTANA PHARMACEUTICALS INC42022–2024
UNIV TEXAS12022
Locations
LocationPatentsSpan
US52022–2024